Ethos Financial Group, LLC Northwest Biotherapeutics Inc Call Options Transaction History
Ethos Financial Group, LLC
- $923 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NWBO
# of Institutions
11Shares Held
728KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC500KShares$130,0310.02% of portfolio
-
Vsm Wealth Advisory, LLC Hunt Valley, MD65.6KShares$17,0490.01% of portfolio
-
Opus Capital Group, LLC60.2KShares$15,6390.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY27KShares$7,0200.0% of portfolio
-
Alpha Mark Advisors, LLC Ft. Wright, KY14KShares$3,6410.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $270M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...